Enjoy complimentary customisation on priority with our Enterprise License!
The liquid biopsy market size is forecast to increase by USD 3.7 billion at a CAGR of 25.2% between 2023 and 2028. The market is experiencing significant growth due to the rising incidence of cancer and increasing investment in this technology for cancer diagnostics. Despite these growth factors, the market faces challenges such as limited reimbursement for liquid biopsy tests. Several key players are making strides in the development and commercialization of liquid biopsy solutions, including breast cancer liquid biopsy testing devices. These companies are focusing on improving the accuracy and accessibility of liquid biopsy tests to address the unmet needs in cancer diagnosis and treatment.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Technology
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.